J Vaňásek

4.9k total citations
44 papers, 418 citations indexed

About

J Vaňásek is a scholar working on Pulmonary and Respiratory Medicine, Radiation and Oncology. According to data from OpenAlex, J Vaňásek has authored 44 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 15 papers in Radiation and 13 papers in Oncology. Recurrent topics in J Vaňásek's work include Advanced Radiotherapy Techniques (15 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Prostate Cancer Treatment and Research (9 papers). J Vaňásek is often cited by papers focused on Advanced Radiotherapy Techniques (15 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Prostate Cancer Treatment and Research (9 papers). J Vaňásek collaborates with scholars based in Czechia, United Kingdom and Belgium. J Vaňásek's co-authors include Michael J. Blaha, Karel Odrážka, Martin Doležel, Petr Paluska, Stanislav Filip, M. Bláha, Jan Jansa, Miloš Broďák, Milan Vošmik and Michal Tichý and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

J Vaňásek

39 papers receiving 402 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J Vaňásek Czechia 9 152 113 109 97 85 44 418
A.duP. Heyns South Africa 10 67 0.4× 5 0.0× 181 1.7× 29 0.3× 117 1.4× 15 375
J. Poschauko Austria 9 51 0.3× 50 0.4× 17 0.2× 9 0.1× 171 2.0× 16 338
Ole H. Larsen Denmark 13 115 0.8× 175 1.6× 74 0.8× 86 1.0× 32 466
Nael Martini United States 8 286 1.9× 13 0.1× 13 0.1× 27 0.3× 180 2.1× 8 570
Charlotte Kristiansen Denmark 10 144 0.9× 57 0.5× 21 0.2× 1 0.0× 62 0.7× 36 316
M.M. Lieber United States 10 365 2.4× 14 0.1× 7 0.1× 9 0.1× 115 1.4× 17 504
Tzung‐Chih Tang Taiwan 14 46 0.3× 2 0.0× 216 2.0× 42 0.4× 37 0.4× 33 507
Lupeng Wu China 20 323 2.1× 3 0.0× 13 0.1× 29 0.3× 613 7.2× 37 1.0k
L Rivabella Italy 7 81 0.5× 169 1.6× 13 0.1× 32 0.4× 14 397
Alberto Agazzi Italy 9 70 0.5× 89 0.8× 9 0.1× 50 0.6× 19 396

Countries citing papers authored by J Vaňásek

Since Specialization
Citations

This map shows the geographic impact of J Vaňásek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J Vaňásek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J Vaňásek more than expected).

Fields of papers citing papers by J Vaňásek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J Vaňásek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J Vaňásek. The network helps show where J Vaňásek may publish in the future.

Co-authorship network of co-authors of J Vaňásek

This figure shows the co-authorship network connecting the top 25 collaborators of J Vaňásek. A scholar is included among the top collaborators of J Vaňásek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J Vaňásek. J Vaňásek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Melichar, Bohuslav, Igor Sirák, J Vaňásek, et al.. (2024). The Role of Adjuvant Radiotherapy in the Treatment of Breast Cancer. Current Oncology. 31(3). 1207–1220. 5 indexed citations
2.
Melichar, Bohuslav, J Vaňásek, Igor Sirák, et al.. (2022). Special Techniques of Adjuvant Breast Carcinoma Radiotherapy. Cancers. 15(1). 298–298. 2 indexed citations
4.
Dušek, Ladislav, Aleš Ryška, Martin Doležel, et al.. (2020). Impact of Hormone Receptor Status on the Behaviour of HER2+ Breast Cancer. In Vivo. 34(6). 3441–3449. 4 indexed citations
5.
Vaňásek, J, Karel Odrážka, Ladislav Dušek, et al.. (2019). Is There a Benefit of HER2-Positive Breast Cancer Subtype Determination in Clinical Practice?. Klinicka onkologie. 32(1).
6.
Vaňásek, J, Karel Odrážka, Bohuslav Melichar, et al.. (2019). Therapeutic significance of hormone receptor positivity in patients with HER-2 positive breast cancer. Biomedical Papers. 163(4). 285–292. 6 indexed citations
7.
Doležel, Martin, Karel Odrážka, Jan Jansa, et al.. (2015). Comparing morbidity and cancer control after 3D-conformal (70/74 Gy) and intensity modulated radiotherapy (78/82 Gy) for prostate cancer. Strahlentherapie und Onkologie. 191(4). 338–346. 29 indexed citations
8.
Vaňásek, J, Karel Odrážka, Ladislav Dušek, et al.. (2014). Experience with intensity-modulated radiotherapy in the treatment of head and neck cancer.. PubMed. 18(4). 970–6. 3 indexed citations
9.
Vaňásek, J, Karel Odrážka, Martin Doležel, et al.. (2013). Statistical Analysis of Dose–Volume Profiles and its Implication for Radiation Therapy Planning in Prostate Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 86(4). 769–776. 5 indexed citations
10.
Vaňásek, J, Karel Odrážka, Ladislav Dušek, et al.. (2012). PET/CT significance for planning radiotherapy of head and neck cancer. Neoplasma. 59(5). 536–540. 5 indexed citations
12.
Doležel, Martin, Karel Odrážka, Ján Žižka, et al.. (2012). MRI-based Preplanning Using CT and MRI Data Fusion in Patients With Cervical Cancer Treated With 3D-based Brachytherapy: Feasibility and Accuracy Study. International Journal of Radiation Oncology*Biology*Physics. 84(1). 146–152. 15 indexed citations
13.
Doležel, Martin, Karel Odrážka, J Vaňásek, et al.. (2011). MRI-based pre-planning in patients with cervical cancer treated with three-dimensional brachytherapy. British Journal of Radiology. 84(1005). 850–856. 17 indexed citations
14.
Odrážka, Karel, Martin Doležel, J Vaňásek, et al.. (2010). Chronická urinární toxicita 3D-CRT a IMRT karcinomu prostaty. 14(3). 156–163. 2 indexed citations
15.
Odrážka, Karel, Martin Doležel, J Vaňásek, et al.. (2010). Late toxicity after conformal and intensity‐modulated radiation therapy for prostate cancer: Impact of previous surgery for benign prostatic hyperplasia. International Journal of Urology. 17(9). 784–790. 20 indexed citations
16.
Odrážka, Karel, Martin Doležel, J Vaňásek, et al.. (2009). Time course of late rectal toxicity after radiation therapy for prostate cancer. Prostate Cancer and Prostatic Diseases. 13(2). 138–143. 25 indexed citations
17.
Odrážka, Karel, et al.. (2000). The role of chemotherapy in prostate cancer. Minireview.. PubMed. 47(4). 197–203. 8 indexed citations
18.
Vávrová, J, Stanislav Filip, Doris Vokurková, et al.. (1999). Ex vivo expansion CD34+/AC133+ - selected autologous peripheral blood progenitor cells (PBPC) in high-risk breast cancer patients receiving intensive chemotherapy. PubMed. 41(3). 105–112. 10 indexed citations
20.
Blaha, Michael J., et al.. (1987). Platelet Transfusion Therapy. JAMA. 257(13). 1777–1777. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026